Protein binding of some nonsteroidal anti-inflammatory drugs studied by high-performance liquid affinity chromatography

International Journal of Pharmaceutics

Volumn 180, Issue 1, 1999, Pages 69-74

  Russeva, Veska N ^a   Zhivkova, Zvetanka D ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Affinity chromatography; Binding sites; Diazepam; Diclofenac sodium; Indomethacin; Markers; Phenylbutazon; Serum albumin; Sulindak

Indexed keywords

DIAZEPAM; DICLOFENAC; HUMAN SERUM ALBUMIN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; SULINDAC;

AFFINITY CHROMATOGRAPHY; BINDING SITE; CONFERENCE PAPER; DRUG PROTEIN BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MATHEMATICAL MODEL; PRIORITY JOURNAL; THEORY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BINDING, COMPETITIVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DICLOFENAC; INDOMETHACIN; PROTEIN BINDING; SERUM ALBUMIN; SULINDAC;

EID: 0032995237     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00397-4     Document Type: Conference Paper

References (12)

1. Domenici E., Bertucci C., Salvadori P., Motellier S., Wainer I.W. Immobilized serum albumin: rapid HPLC probe of stereoselective protein binding interactions. Chirality. 2:1990;263-268.
2. Domenici E., Bertucci C., Salvadori P., Wainer I.W. Use of a human serum albumin -based chiral stationary phase for high-performance liquid chromatography for the investigation of protein binding: detection of the allosteric interaction between warfarin and benzodiazepine binding sites. J. Pharm. Sci. 80:1991;164-169.
3. Ekman B., Sjodin T., Sjoholm I. Binding of drugs to human serum albumin-XV. Characterization and identification of the binding sites of indomethacin. Biochem. Pharmacol. 29:1980;1759-1765.
4. Honore B., Brodersen R. Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis. Mol. Pharmacol. 25:1984;137-150.
5. Mason R.W., McQueen E.G. Protein binding of indomethacin: binding of indomethacin to human plasma albumin and its displacement from binding by ibuprofen, phenylbutazone and salicylate, in vitro. Pharmacology. 12:1974;12-19.
6. Russeva V., Stavreva N., Rakovska R., Michailova D. Binding of sulindak to human serum albumin studied by circular dichroism. Arzneim.-Forsch./Drug Res. 44(I)(2):1994;159-162.
7. Russeva V., Mihailova D. Modelling of indometacin and diclofenac sodium binding to the molecule of human serum albumin. Arzneim.-Forsch./Drug Res. 46(I)(3):1996;288-292.
8. Russeva V., Zhivkova Z. Albumin binding sites studied by high-performance liquid affinity chromatography. Int. J. Pharm. 168:1998;23-29.
9. Sjoholm I., Ekman B., Kober A., Ljungstedt-Pahlman I., Seiving B., Sjodin T. Binding of drugs to human serum albumin: XI. The specificity of three binding sites as studied with albumin immobilized in microparticles. Mol. Pharmacol. 16:1979;767-777.
10. Sjoholm I., Kober A. Binding of drugs to human serum albumin with special reference to the binding of some anti-rheumatic agents. Br. J. Clin. Pract., Symp. Suppl. 6:1980;6-9.
11. R) an Serum-proteine verschiedener Spezies und Interaktionen mit anderen Pharmaka. Akt. Rheumatol. 4:1979;153-162.
12. Zhivkova Z., Russeva V. New mathematical approach for evaluating of drug binding to human serum albumin by high-performance liquid affinity chromatography. J. Chromatogr. B. 707:1998;143-149.